SCHEMBL31423024

SCHEMBL31423024

CCOC(=O)c1cc2ccc(B3OC(C)(C)C(C)(C)O3)cc2nc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ UCHL1 P09936 1/20 0.41
▸ MAOB P27338 6/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ TSHR P16473 2/20 0.37
▸ MIF P14174 1/20 0.37
▸ PFKFB3 Q16875 1/20 0.37
▸ HIF1A Q16665 2/20 0.36
▸ ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22397168 0.79 CYP1A2 (0.40) KDM4EALDH1A1UCHL1HIF1ADGAT1
SCHEMBL5064664 0.78 UCHL1 (0.43) KDM4EALDH1A1UCHL1CA12CA2
SCHEMBL3517005 0.78 UCHL1 (0.43) ALDH1A1UCHL1GAATSHRHIF1A
SCHEMBL31423090 0.77 ALDH1A1 (0.48) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL31422780 0.77 ALDH1A1 (0.53) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL17206222 0.76 UCHL1 (0.39) UCHL1MAOBCA12CA2CA3
SCHEMBL2782538 0.76 CA1 (0.43) KDM4EALDH1A1UCHL1CA12CA2
SCHEMBL10184702 0.76 TSHR (0.42) ALDH1A1UCHL1CA12CA2GAA
SCHEMBL31423318 0.76 ALDH1A1 (0.47) KDM4EALDH1A1HPGDMAOBCA12
SCHEMBL14929238 0.75 CA1 (0.56) KDM4EHPGDUCHL1MAOBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 — — WO disclosed
Send feedback